Exploring the Role and Impact of the Drug Czar in U.S. Drug Policy
In a recent interview, Rahul Gupta, Director of the Office of National Drug Control Policy (ONDCP), strongly criticized the failed policies of cannabis prohibition pushed by the U.S. Drug Czar. He highlighted the impacts these policies have had on communities, stating that many have been “upended” due to cannabis-related arrests. Gupta aligned with President Joe Biden’s stance that no one should be jailed for cannabis possession, emphasizing how convictions can hinder access to housing and jobs.
Cannabis Rescheduling to Encourage Research and Drug Development
Gupta discussed the Biden administration’s push to reschedule cannabis from a Schedule I to a Schedule III substance under the Controlled Substances Act (CSA). This move, while not legalizing cannabis, would ease research restrictions, allowing for greater exploration of cannabis’s medicinal potential. Rescheduling would also help pave the way for the development of cannabis-based drugs, which would undergo FDA approval processes.
The rescheduling could improve access to treatments for chronic conditions such as cancer and chronic pain. Gupta explained that under the current Schedule I rank, researchers face significant obstacles, leading to a “catch-22” where more research is demanded, yet difficult to conduct.
Possible Benefits of Rescheduling
While optimistic about the prospects of rescheduling, Gupta acknowledged that it remains abstract whether medical companies will focus on cannabis-based drug development. Currently, synthetic THC and CBD-based medications are already FDA-approved, and further research could lead to new approvals. However, Gupta noted that cannabis in its botanical form is unlikely to be approved for prescription use.
The Congressional Research Service (CRS) report emphasized that additional actions from the FDA would be necessary before cannabis products could be made available by prescription.
Confusion Over Federal Legalizing
During the interview, Gupta sidestepped a question about whether Congress should federally legalize cannabis. Instead, he referenced President Biden’s frustration with Congress’s inaction on cannabis reform, which prompted the authority’s scheduling review. However, Biden does not support full federal legalization, preferring to allow states to set their own policies.
Gupta reiterated that the government is doing what it can within the existing legal framework, but acknowledged that Congress has the power to take further steps. He underscored the importance of evidence-based policy changes to address the criminal justice effects of prohibition.
Opposition to Cannabis Rescheduling
While Gupta promotes the potential benefits of rescheduling, not all former drug policy leaders agree. Former ONDCP Director Gil Kerlikowske, who served under President Barack Obama, voiced strong opposition, claiming that rescheduling is driven by “Big Cannabis” interests and likening the industry to Big Tobacco.
Public Comment and Legal Challenges
The federal government has officially opened the public comment period for the proposed cannabis rescheduling. Supporters and opponents of cannabis reform are expected to submit a range of feedback. While some advocate for a full rollback of scheduling, others seek to keep cannabis classified as a Schedule I drug. The Department of Justice (DOJ) is especially interested in hearing about the potential economic impacts of rescheduling, given the multibillion-dollar state-level cannabis industry that could benefit from federal tax relief.
Legislative Prospects and Future Reforms
Majority Leader Chuck Schumer and his colleagues have reintroduced legislation to federally legalize cannabis, but the bill faces uncertainty. However, rescheduling is viewed by many, including the top Democrat in the U.S. House, as a “step in the right direction” that could lead to more substantial reforms down the line.
Meanwhile, the government continues to push forward with cannabis-related reforms, having already issued mass pardons for federal cannabis possession offenses. Although rescheduling won’t legalize cannabis or free those still incarcerated, it represents significant progress in federal czar drug policy.
Original Article: Click Here
More Business + Law Articles: Click Here